These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18096714)

  • 1. Muscle atrophy and hypertrophy signaling pathways in COPD: a role in muscle remodeling?
    Langen RC; Schols AM
    Am J Respir Crit Care Med; 2008 Jan; 177(1):122; author reply 122-3. PubMed ID: 18096714
    [No Abstract]   [Full Text] [Related]  

  • 2. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy.
    Léger B; Cartoni R; Praz M; Lamon S; Dériaz O; Crettenand A; Gobelet C; Rohmer P; Konzelmann M; Luthi F; Russell AP
    J Physiol; 2006 Nov; 576(Pt 3):923-33. PubMed ID: 16916907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease.
    Doucet M; Russell AP; Léger B; Debigaré R; Joanisse DR; Caron MA; LeBlanc P; Maltais F
    Am J Respir Crit Care Med; 2007 Aug; 176(3):261-9. PubMed ID: 17478621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy.
    Glass DJ
    Nat Cell Biol; 2003 Feb; 5(2):87-90. PubMed ID: 12563267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrogin-1, MuRF1, and FoXO, as well as phosphorylated GSK-3beta and 4E-BP1 are reduced in skeletal muscle of chronic spinal cord-injured patients.
    Léger B; Senese R; Al-Khodairy AW; Dériaz O; Gobelet C; Giacobino JP; Russell AP
    Muscle Nerve; 2009 Jul; 40(1):69-78. PubMed ID: 19533653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.
    Stitt TN; Drujan D; Clarke BA; Panaro F; Timofeyva Y; Kline WO; Gonzalez M; Yancopoulos GD; Glass DJ
    Mol Cell; 2004 May; 14(3):395-403. PubMed ID: 15125842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
    Castillero E; Alamdari N; Lecker SH; Hasselgren PO
    Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary fish oil alleviates soleus atrophy during immobilization in association with Akt signaling to p70s6k and E3 ubiquitin ligases in rats.
    You JS; Park MN; Song W; Lee YS
    Appl Physiol Nutr Metab; 2010 Jun; 35(3):310-8. PubMed ID: 20555375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron-induced skeletal muscle atrophy involves an Akt-forkhead box O3-E3 ubiquitin ligase-dependent pathway.
    Ikeda Y; Imao M; Satoh A; Watanabe H; Hamano H; Horinouchi Y; Izawa-Ishizawa Y; Kihira Y; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
    J Trace Elem Med Biol; 2016 May; 35():66-76. PubMed ID: 27049128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-(1-7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism.
    Cisternas F; Morales MG; Meneses C; Simon F; Brandan E; Abrigo J; Vazquez Y; Cabello-Verrugio C
    Clin Sci (Lond); 2015 Mar; 128(5):307-19. PubMed ID: 25222828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular determinants of skeletal muscle mass: getting the "AKT" together.
    Nader GA
    Int J Biochem Cell Biol; 2005 Oct; 37(10):1985-96. PubMed ID: 16125108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal muscle dysfunction in idiopathic pulmonary arterial hypertension.
    Batt J; Ahmed SS; Correa J; Bain A; Granton J
    Am J Respir Cell Mol Biol; 2014 Jan; 50(1):74-86. PubMed ID: 23972212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1/Akt signaling in C2C12 myotubes.
    Tong JF; Yan X; Zhu MJ; Du M
    J Cell Biochem; 2009 Oct; 108(2):458-68. PubMed ID: 19639604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of ubiquitin ligase inhibitor as a drug against unloading-mediated muscle atrophy].
    Nikawa T
    Seikagaku; 2009 Jul; 81(7):614-8. PubMed ID: 19697867
    [No Abstract]   [Full Text] [Related]  

  • 15. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
    Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
    Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the FoxO1/MuRF1/Atrogin-1 Signaling Pathway in the Oxidative Stress-Induced Atrophy of Cultured Chronic Obstructive Pulmonary Disease Myotubes.
    Pomiès P; Blaquière M; Maury J; Mercier J; Gouzi F; Hayot M
    PLoS One; 2016; 11(8):e0160092. PubMed ID: 27526027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The kinin B1 receptor regulates muscle-specific E3 ligases expression and is involved in skeletal muscle mass control.
    Parreiras-E-Silva LT; Reis RI; Santos GA; Pires-Oliveira M; Pesquero JB; Gomes MD; Godinho RO; Costa-Neto CM
    Clin Sci (Lond); 2014 Aug; 127(3):185-94. PubMed ID: 24498923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal muscle hypertrophy and atrophy signaling pathways.
    Glass DJ
    Int J Biochem Cell Biol; 2005 Oct; 37(10):1974-84. PubMed ID: 16087388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin ligase gene expression in healthy volunteers with 20-day bedrest.
    Ogawa T; Furochi H; Mameoka M; Hirasaka K; Onishi Y; Suzue N; Oarada M; Akamatsu M; Akima H; Fukunaga T; Kishi K; Yasui N; Ishidoh K; Fukuoka H; Nikawa T
    Muscle Nerve; 2006 Oct; 34(4):463-9. PubMed ID: 16868939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hindlimb casting decreases muscle mass in part by proteasome-dependent proteolysis but independent of protein synthesis.
    Krawiec BJ; Frost RA; Vary TC; Jefferson LS; Lang CH
    Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E969-80. PubMed ID: 16046454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.